7 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Unknown 7 |
Follow Memory Impairment: new trials by email Literature Review of Memory Impairment trials Research Report on Memory Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints RehaCom - COVID-19, Cognitive Impairment | Not applicable | Unknown | Erasmus Medical Center | 50 | 2023-12-01 | 2024-03-13 |
| Investigating the Efficacy of ApplTree on Prospective Memory in Stroke ApplTree smartphone application - Stroke (CVA) or TIA, Memory Impairment | Not applicable | Unknown | NHS Greater Glasgow and Clyde | 6 | 2023-01-01 | 2022-12-20 |
| Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) GammaSense Stimulation System (non-invasive, non-significant risk) - Alzheimer Disease, Early Onset, Alzheimer Disease | Not applicable | Unknown | Cognito Therapeutics, Inc. | 20 | 2018-05-31 | 2021-08-24 |
| Examining the Effect of a Simple Memory Tool simple memory tool - Memory Impairment | Not applicable | Unknown | University of Manitoba | 30 | 2017-06-01 | 2017-08-09 |
| Memory Intervention for Older Adults - (Social) memory - Memory Impairment | Not applicable | Unknown | University of Manitoba | 12 | 2015-08-01 | 2016-05-10 |
| Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II) Fruitflow-II, resVida - Memory Impairment | Not applicable | Unknown | Neurolgy Institute for Brain Health and Fitness | 80 | 2013-01-01 | 2015-04-21 |
| A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness. Memory Intervention - Memory Impairment | Not applicable | Unknown | St. Joseph's Healthcare Hamilton | 76 | 2012-10-01 | 2012-10-16 |
Memory Disorders (7) · Cognitive Dysfunction (2) · Alzheimer Disease (1) · Attention Deficit Disorder with Hyperactivity (1) · COVID-19 (1) · Cognition Disorders (1) · Dementia (1) · Lymphoma, Follicular (1) · Mental Disorders (1) · Stroke (1)
Nervous System Diseases (7) · Neurobehavioral Manifestations (7) · Neurologic Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Brain Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2) · Neurocognitive Disorders (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Cognition Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1)
Resveratrol (1)
University of Manitoba (2) · Cognito Therapeutics, Inc. (1) · Erasmus Medical Center (1) · NHS Greater Glasgow and Clyde (1) · Neurolgy Institute for Brain Health and Fitness (1) · St. Joseph's Healthcare Hamilton (1)
Canada (2) · United States (2) · Netherlands (1)
Bruno J Losier, Ph.D. (1) · Evan R Hempel (1) · Gerard Ribbers, Professor (1) · Jonathan J Evans, BSc, PsyD, PhD (1) · Majid Fotuhi, MD, PhD (1) · Mehrnoosh Hadadi, MD, MPH (1) · Verena Menec, PhD (1) · Verena Menec, Phd (1)